Globe Life Inc. (NYSE:GL) Shares Sold by Tweedy Browne Co LLC

Tweedy Browne Co LLC trimmed its stake in shares of Globe Life Inc. (NYSE:GL) by 6.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 33,234 shares of the company’s stock after selling 2,268 shares during the quarter. Globe Life comprises 0.2% of Tweedy Browne Co LLC’s portfolio, making the stock its 29th largest position. Tweedy Browne Co LLC’s holdings in Globe Life were worth $3,706,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its position in Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock worth $27,000 after purchasing an additional 194 shares during the last quarter. Albion Financial Group UT bought a new position in Globe Life in the 4th quarter worth approximately $28,000. Rakuten Securities Inc. acquired a new stake in Globe Life in the 4th quarter valued at approximately $28,000. Avalon Trust Co acquired a new stake in Globe Life in the 4th quarter valued at approximately $41,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in Globe Life by 32.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company’s stock worth $41,000 after purchasing an additional 90 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Frank M. Svoboda sold 11,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $122.31, for a total value of $1,345,410.00. Following the transaction, the chief executive officer now directly owns 18,948 shares of the company’s stock, valued at approximately $2,317,529.88. This trade represents a 36.73 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CMO Jennifer Allison Haworth sold 9,000 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the completion of the sale, the chief marketing officer now owns 13,485 shares of the company’s stock, valued at $1,522,591.35. The trade was a 40.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 61,338 shares of company stock valued at $7,239,630 over the last three months. 1.51% of the stock is currently owned by insiders.

Globe Life Stock Up 1.6 %

GL stock opened at $131.83 on Tuesday. Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $132.50. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The company has a market cap of $10.97 billion, a price-to-earnings ratio of 11.03 and a beta of 0.77. The company has a 50 day moving average of $124.25 and a two-hundred day moving average of $114.21.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, equities analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be issued a $0.27 dividend. The ex-dividend date is Thursday, April 3rd. This is a boost from Globe Life’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.82%. Globe Life’s dividend payout ratio is currently 9.04%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Morgan Stanley upped their target price on Globe Life from $125.00 to $126.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Jefferies Financial Group lifted their price objective on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research note on Tuesday, December 10th. Keefe, Bruyette & Woods increased their target price on shares of Globe Life from $137.00 to $145.00 and gave the company an “outperform” rating in a research note on Wednesday, February 12th. BMO Capital Markets initiated coverage on shares of Globe Life in a report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 target price for the company. Finally, Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and upped their target price for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $135.60.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.